Home

Select a country

Welcome

ClinRegs is an online database of country-specific clinical research regulatory information designed to assist in planning and implementing international clinical research. Countries are included based on NIAID's international clinical research priorities. For additional information, see the About page. 

If a country you are looking for is not included in ClinRegs, consider the following resources:

Check out the ClinRegs fact sheet and share it with your colleagues!

Check out a replay of our May 23, 2024, webinar: Utilizing NIAID’s ClinRegs Website to Support International Clinical Research Regulatory Compliance. The webinar provides background on the site, a demo that highlights the site functionality and navigation, details on how the information is kept-up-to date, current usage trends, and how to stay engaged.

 

Updates

KEN flag Kenya Profile Updated

Jul 2, 2024 - The Kenya profile in ClinRegs has been reviewed and updated with the following information:Minor revisions to the Pharmacy and Poisons Board (PPB) guidance for the conduct of clinical trials, including an updated definition of investigational product, name change for the PPB clinical trial ...

IND flag India Profile Updated

Jun 21, 2024 - The India profile in ClinRegs has been reviewed and updated with the following information:2024 Central Drugs Standard Control Organization (CDSCO) Notice on the National Single Window System (NSWS) online portal launch and related resources (See Regulatory Fees, Submission ...

VNM flag Vietnam Profile Updated

May 22, 2024 - The Vietnam profile in ClinRegs has been reviewed and updated with the following information: Updated documentation for the 2023-2028 term of the National Ethics Committee in Biomedical Research (See Ethics Committee and Scope of Review)Additional Ministry of Public Security personal data ...

GBR flag UK Profile Updated

May 16, 2024 - The United Kingdom profile in ClinRegs has been reviewed and updated with the following information: Updated Medicines and Healthcare Products Regulatory Agency (MHRA) guidance on a new notification scheme when applying for authorization to conduct a clinical trial (See Scope of Assessment ...